y.adebayo
TL2 · Basel
Contributes reviews on supplier material. Based in Basel.
Joined 11 February 2025 · last posted 3d
67Posts here
1Topics
0Solutions
1.2kLikes received
845Likes given
22Badges
255Days visited
4.9kPosts read
Recent activity
Full stream-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #24 · Analytics › COA interpretation · 24 Jul 2026 · 4 likes Answering the question post #22 raises rather than the one it answers. An itemised related-substances table with retention times says considerably more about the…
-
How shortages have affected compounding permissions Replied, post #65 · Access › Shortages · 24 Jul 2026 · 19 likes Shortages is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
What is genuinely unknown about long-term amylin agonism Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2026 · 0 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Research-use-only cagrilintide is not approved for human use and the published…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #79 · Analytics › Method validation · 6 Jul 2026 · 12 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
Micro-titration: a disputed topic, argued properly Replied, post #92 · Practice › Dosing & titration · 20 Jun 2026 · 1 like Summarising the micro-titration thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #57 · Evidence › Journal club · 15 Jun 2026 · 32 likes Worth separating SURMOUNT-1 as a question about the compound from SURMOUNT-1 as a question about the documentation. They get answered by different people and only one…
-
What a certificate commits its issuer to — one year on Replied, post #87 · Analytics › COA interpretation · 12 Jun 2026 · 25 likes Narrowing post #84, because the general version has more than one answer. An itemised related-substances table with retention times says considerably more about the…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #66 · Devices › Syringes & needles · 8 Jun 2026 · 3 likes Confirming post #64 from a second method, which matters more than confirming it from a second person. Two people in this thread mean different things by 0.3 ml versus…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #37 · Compounds › Repair & healing peptides · 5 Jun 2026 · 6 likes Offering a way to settle absence of controlled human data rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #55 · Access › Insurance & coverage · 5 Jun 2026 · 9 likes Taking post #53 at face value and following it one step further. The claim about appeal upthread is stronger than its source supports. I have read the source. The…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #35 · Practice › Storage & stability · 3 Jun 2026 · 22 likes Where the reconstituted reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
How to disagree with an answer you were given, well Replied, post #4 · Start Here › How to Ask · 30 May 2026 · 2 likes Everything in post #2 holds. The case it does not cover is the one I have. Five questions in one post gets you one answer: the easiest one, usually not the one you…